Tus kws kho mob
P12-21 Early Intensive Developmental and Behavioral Intervention (EIDBI) Service Authorization for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1811 - 1820 ntawm 4204
Tus kws kho mob
P7-21 Change in Liability for Members of Other Blue Plans
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2021
Tus kws kho mob
Upcoming-med-policies-effective-April-5-2021.pdf
Tus kws kho mob
QP5-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sucraid® (sacrosidase) PAQL
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2021
Tus kws kho mob
QP7-21 Replacement Claim Submission Guidelines
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2021
Tus kws kho mob
QP6-21 MHCP Pharmacy Benefit Exclusion for OxlumoTM and Danyelza®
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2021
Tus kws kho mob
QP8-21 Change in Suspect COVID-19 Diagnosis Code
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2021
Tus kws kho mob
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2021
Tus kws kho mob
QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 13, 2021